Re: Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for MB
Quote:
The subanalysis of patients who progressed after first-linetrastuzumab suggests that continuing trastuzumab TBP offersclinical benefit to patients with HER-2+ MBC treated initiallywith first-line trastuzumab